Trifucosyl-Lewis y Antigen
General | Antibody | Glycoprotein | Glycolipid | Enzyme | ReferenceEpitope information of EP0094
| Epitope ID | EP0094 |
|---|---|
| Epitope name | Trifucosyl-Lewis y Antigen |
| Structure |  |
| Sequence | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| Aliases | Trifucosyl-Leyantigen, Ley/Lex antigen |
| History | Ley-active trifucosylnonaosylceramide isolated from human colonic adenocarcinoma (Nudelman,E.,Levery,S.B.,Kaizu,T.,and Hakomori,S.(1986)).[2*][1*] |
| DB | GlyTouCan:G74917JX JCGGDB |
| Molecular weight | 1187.1 |
| Composition | (Fuc)3(Gal)2(GlcNAc)2 |
| Species | Homo sapiens |
| Tissue and Cellular distribution | cancer/colon/adenocarcinoma |
| Subcellular distribution | |
| Developmental change | |
| Cell line | |
| Receptor | |
| Function | |
| Diseases | colonic adenocarcinomia |
| Application | |
| Comment |